TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
KURA

Kura Oncology Inc

Healthcare · Biotechnology

10.70$ +1.3% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Kura Oncology Inc (KURA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 588 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KURA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
474 449 554 515 479 760 744 682 649 738 653 588
460 432 538 500 463 745 724 660 621 709 624 559
29 37 42 45 49 224 51 82 95 149 39 70
453 424 527 492 455 727 658 631 550 667 581 519
– 2.8 – – – 6.1 49 4.6 39 13 14 9.4
– – – – – 0.0 – – – 0.4 0.8 2.5
44 52 49 49 55 347 379 377 407 564 545 539
28 35 32 33 40 79 90 107 121 117 101 118
1.7 1.5 1.4 2.3 3.4 4.5 3.8 4.8 5.8 1.3 1.3 5.5
1.8 2.3 7.5 2.1 3.0 1.5 4.6 1.7 4.7 5.0 7.0 2.4
9.3 9.3 9.4 8.6 7.8 6.9 7.7 6.5 5.3 9.7 9.7 5.6
430 397 505 466 424 414 364 305 243 174 108 48
-679 -721 -771 -822 -876 -895 -953 -1,019 -1,093 -1,174 -1,247 -1,316
77 77 84 87 87 87 87 88 88 88 89 89

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?